CME Group Terry Duffy Will Step Down as Chief Executive Officer and Transition to Executive Chairman of the Board in March 2027; President and CFO Lynne Fitzpatrick Will Be Appointed CEO
Rhea-AI Summary
CME Group (Nasdaq:CME) announced that longtime Chairman and CEO Terry Duffy will step down as Chief Executive Officer and transition to Executive Chairman on March 1, 2027. Lynne Fitzpatrick, currently President and CFO, will become CEO and join the Board at that time.
Duffy led CME Group through major transformations, including mergers and acquisitions, and oversaw growth to an average daily volume of 28.1 million contracts in the prior year and a market capitalization above $95 billion, which the company reports is more than 8,000% higher than in 2002.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- Planned CEO transition on March 1, 2027, giving investors long lead time
- Outgoing CEO Terry Duffy to remain as Executive Chairman for continuity
- Internal successor Lynne Fitzpatrick has 20+ years of strategic and financial experience
- Fitzpatrick has served as President and CFO since 2024, supporting leadership stability
- Company reports market cap above $95 billion, up over 8,000% since 2002 IPO
- Average daily volume reached 28.1 million contracts in the prior year
Negative
- None.
News Market Reaction – CME
On the day this news was published, CME declined 3.46%, reflecting a moderate negative market reaction. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $3.40B from the company's valuation, bringing the market cap to $94.79B at that time.
Data tracked by StockTitan Argus on the day of publication.
Duffy has been at the helm of CME Group for more than 25 years when he was appointed Chairman in 2002, then Executive Chairman in 2006 and Chairman and Chief Executive Officer in 2016. Throughout his tenure, Duffy has led the company, and in turn the industry, through significant and ongoing transformation. He built a global trading powerhouse that traded an average daily volume of 28.1 million contracts last year and commands a market cap of more than
Under Duffy's leadership, CME Group transitioned from floor-based to electronic trading and became the first
"Leading CME Group through more than 25 years of transformative growth has been among the highest honors of my life," said Duffy. "Since first stepping onto the trading floor in the 1980s, I have been a believer that strong, transparent and regulated markets are a powerful force in driving progress for economies, businesses and individuals. Together with my Board, colleagues both past and present, and our employees across the globe, I am proud to have played a role in turning my conviction into history, as CME Group has grown from a
"I am pleased our company is so well positioned and have never been more optimistic about its future potential. As I begin this transition to Executive Chairman, I look forward to working even more closely with Lynne, our soon-to-be CEO, to deliver enhanced benefits to our clients and new value for our shareholders. With more than 20 years of strategic and financial expertise and strong leadership abilities, Lynne is the right person at the right time. She will continue moving our company forward for our clients, shareholders and our entire global team."
"On behalf of the CME Group Board, I thank Terry for his tremendous leadership, not only as the longest running Chairman and CEO in our company's history, but also as the foremost champion of our business, our markets and the global futures industry," said Charlie Carey, Lead Director of the CME Group Board of Directors. "As a friend and colleague for more than 40 years, I've had a front row seat to watch Terry successfully deploy the strategic vision that has propelled CME Group into one of the strongest global financial services organizations in the world. We are pleased he will remain as Executive Chairman to work with Lynne, a strong, accomplished leader in her own right, as she steps into the role of CEO and continues to build and expand our company's leading position in this very dynamic marketplace."
Fitzpatrick said, "It is my privilege to have been able to work with and learn from Terry over the last 20 years, and I am honored to have the opportunity to succeed him as CEO next March. I appreciate the confidence that he and the Board have placed in me, and I look forward to working with our investors, clients and employees around the world as we grow our core business and create value for our shareholders."
Duffy Biographical Information
A leading voice of the financial industry, Duffy joined CME Group as a runner in the lean hog pit in 1980. He purchased a seat to become a member and founded his trading company, TDA Trading, in 1981. Duffy joined the Board of Chicago Mercantile Exchange in 1995, was named Vice Chairman in 1998 and Chairman in 2002. He became Executive Chairman of the Board of CME Group in 2006, Executive Chairman and President in 2012, and was named to his current role of Chairman and CEO in 2016. He regularly testifies before Congress on key issues facing derivatives markets, clients and global market users. He has been named FOW's International CEO of the Year, one of TabbFORUM's 40 Innovators in Financial Markets, a member of the Futures Industry Association's Hall of Fame and included in Crain's Who's Who in Chicago Business. Under his leadership, CME Group has received a wide range of industry awards recognizing the company, clearing house, technology, product innovation and brand value.
Duffy was inducted into the Futures Industry Hall of Fame by the Futures Industry Association in 2025. He was appointed by President Bush and confirmed by the
He serves as Co-Chair of the Mayo Clinic Greater Chicago Leadership Council and is a Board member of the CME Group Foundation.
He attended the University of
Fitzpatrick Biographical Information
Fitzpatrick was appointed President and Chief Financial Officer in 2024. She previously served as Chief Financial Officer since 2023, Deputy Chief Financial Officer since 2022 and Managing Director of Corporate Development and Treasurer since 2017.
Since joining CME Group in 2006, Fitzpatrick has held a variety of positions with increasing levels of responsibility within the organization. She previously worked as an investment banker at Credit Suisse and UBS.
Fitzpatrick has been named to Crain's 40 Under 40 and recognized as one of Crain's Chicago Business Notable Leaders in Finance.
She holds a bachelor's degree in economics from Brown University and an MBA from the University of Chicago Booth School of Business.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and
CME-G
View original content:SOURCE CME Group